These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 15034951
1. Adult growth hormone deficiency. Metabolic alterations and evaluation of different risk groups. Fideleff HL, Chervin A, Giaccio A, Sobrado P, Barmat R, Boquete H, Kabi International Metabolic Study Argentine Group. Medicina (B Aires); 2004; 64(1):13-9. PubMed ID: 15034951 [Abstract] [Full Text] [Related]
2. Medium and long-term outcome of growth hormone therapy in growth hormone deficient adults. Fideleff HL, Boquete H, Giaccio A, Sobrado P, KIMS, Argentine Group. Medicina (B Aires); 2006; 66(4):296-302. PubMed ID: 16977963 [Abstract] [Full Text] [Related]
3. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG. Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903 [Abstract] [Full Text] [Related]
7. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ. J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238 [Abstract] [Full Text] [Related]
8. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency. Szczepańiska Kostro J, Tołwińska J, Urban M, Gardziejczyk M, Głowińska B. J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719 [Abstract] [Full Text] [Related]
9. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report. Bohdanowicz-Pawlak A, Szymczak J, Bladowska J, Bednarek-Tupikowska G, Bidzińska B, Milewicz A. Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951 [Abstract] [Full Text] [Related]
10. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency. Benedini S, Dalle Carbonare L, Albiger N, Scanarini M, Bilora F, Petrobelli F, Giannini S, Mantero F, Scaroni C. Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535 [Abstract] [Full Text] [Related]
11. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone. Bell W, Davies JS, Evans WD, Scanlon MF, Mullen R. Am J Hum Biol; 2004 Jan; 16(5):533-43. PubMed ID: 15368601 [Abstract] [Full Text] [Related]
12. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Kendall-Taylor P, Jönsson PJ, Abs R, Erfurth EM, Koltowska-Häggström M, Price DA, Verhelst J. Eur J Endocrinol; 2005 Apr; 152(4):557-67. PubMed ID: 15817911 [Abstract] [Full Text] [Related]
13. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency]. Olsovská V, Siprová H, Beránek M, Soska V. Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102 [Abstract] [Full Text] [Related]
14. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database. Attanasio AF, Bates PC, Ho KK, Webb SM, Ross RJ, Strasburger CJ, Bouillon R, Crowe B, Selander K, Valle D, Lamberts SW, Hypoptiuitary Control and Complications Study International Advisory Board. J Clin Endocrinol Metab; 2002 Apr; 87(4):1600-6. PubMed ID: 11932289 [Abstract] [Full Text] [Related]
15. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P, KIMS Study Group. Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692 [Abstract] [Full Text] [Related]
16. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism. Kosowicz J, El Ali Z, Ziemnicka K, Sowinski J. J Clin Densitom; 2007 Oct; 10(3):332-9. PubMed ID: 17470407 [Abstract] [Full Text] [Related]
17. Cardiovascular risk factors in obese women and their first-degree relatives. Saraç F, Ozgen AG, Yilmaz C, Tüzün M. Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331 [Abstract] [Full Text] [Related]
18. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency. Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H. Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020 [Abstract] [Full Text] [Related]
19. Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults. Chehrei A, Sadrnia S, Keshteli AH, Daneshmand MA, Rezaei J. Asia Pac J Clin Nutr; 2007 Apr; 16(2):248-53. PubMed ID: 17468079 [Abstract] [Full Text] [Related]